Terms: = Endocrine gland cancer AND HNF1A, HNF1, 6927, ENSG00000135100, TCF1, MODY3, P20823, LFB1 AND Treatment
11 results:
1. WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer.
Du W; Menjivar RE; Donahue KL; Kadiyala P; Velez-Delgado A; Brown KL; Watkoske HR; He X; Carpenter ES; Angeles CV; Zhang Y; Pasca di Magliano M
J Exp Med; 2023 Jan; 220(1):. PubMed ID: 36239683
[TBL] [Abstract] [Full Text] [Related]
2. hnf1a inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1.
Lu Y; Xu D; Peng J; Luo Z; Chen C; Chen Y; Chen H; Zheng M; Yin P; Wang Z
EBioMedicine; 2019 Jun; 44():403-418. PubMed ID: 31103629
[TBL] [Abstract] [Full Text] [Related]
3. Alpha-fetoprotein-producing ovarian clear cell adenocarcinoma with fetal gut differentiation: a rare case report and literature review.
Chao WT; Liu CH; Lai CR; Chen YJ; Chuang CM; Wang PH
J Ovarian Res; 2018 Jun; 11(1):52. PubMed ID: 29933751
[TBL] [Abstract] [Full Text] [Related]
4. MicroRNA-214 Suppresses Ovarian cancer by Targeting β-Catenin.
Liu Y; Lin J; Zhai S; Sun C; Xu C; Zhou H; Liu H
Cell Physiol Biochem; 2018; 45(4):1654-1662. PubMed ID: 29486472
[TBL] [Abstract] [Full Text] [Related]
5. Applying Precision Medicine to Ovarian cancer: Proof-of-Principle for a "Molecular Second Look".
Schwartz M; Camacho-Vanegas O; Wood AM; Dashkoff M; Whitelock C; Harkins TT; Cohen CJ; Beddoe AM; Dottino P; Martignetti JA
Int J Gynecol Cancer; 2018 Mar; 28(3):479-485. PubMed ID: 29324546
[TBL] [Abstract] [Full Text] [Related]
6. Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and treatment Response.
Muckenhuber A; Berger AK; Schlitter AM; Steiger K; Konukiewitz B; Trumpp A; Eils R; Werner J; Friess H; Esposito I; Klöppel G; Ceyhan GO; Jesinghaus M; Denkert C; Bahra M; Stenzinger A; Sprick MR; Jäger D; Springfeld C; Weichert W
Clin Cancer Res; 2018 Jan; 24(2):351-359. PubMed ID: 29101303
[No Abstract] [Full Text] [Related]
7. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
[TBL] [Abstract] [Full Text] [Related]
8. Antitumor efficacy of α-solanine against pancreatic cancer in vitro and in vivo.
Lv C; Kong H; Dong G; Liu L; Tong K; Sun H; Chen B; Zhang C; Zhou M
PLoS One; 2014; 9(2):e87868. PubMed ID: 24505326
[TBL] [Abstract] [Full Text] [Related]
9. Epigenetic determinants of ovarian clear cell carcinoma biology.
Yamaguchi K; Huang Z; Matsumura N; Mandai M; Okamoto T; Baba T; Konishi I; Berchuck A; Murphy SK
Int J Cancer; 2014 Aug; 135(3):585-97. PubMed ID: 24382740
[TBL] [Abstract] [Full Text] [Related]
10. INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells.
Bonner C; Bacon S; Concannon CG; Rizvi SR; Baquié M; Farrelly AM; Kilbride SM; Dussmann H; Ward MW; Boulanger CM; Wollheim CB; Graf R; Byrne MM; Prehn JH
Diabetes; 2010 Nov; 59(11):2799-808. PubMed ID: 20682686
[TBL] [Abstract] [Full Text] [Related]
11. Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management.
Mandai M; Yamaguchi K; Matsumura N; Baba T; Konishi I
Int J Clin Oncol; 2009 Oct; 14(5):383-91. PubMed ID: 19856044
[TBL] [Abstract] [Full Text] [Related]